UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
33.48
-0.27 (-0.80%)
At close: Oct 29, 2026, 4:00 PM EDT
32.55
-0.93 (-2.78%)
After-hours: Oct 29, 2026, 7:30 PM EDT
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $1.64 billion as of October 29, 2026. It is the 7,455th most valuable company in the world and the 1,912th biggest in the United States. Its market cap has increased by 75.29% in one year.
Market Cap
1.64B
Enterprise Value
1.72B
1-Year Change
75.29%
Global Rank
Country Rank
#1,912 United States
Category
ChartMarket Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $1.64B, an increase of 799.68%. That is a compound annual growth rate of 26.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 1.64B | 49.28% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hemab Therapeutics Holdings | 1.74B |
| Nanobiotix | 1.71B |
| Kailera Therapeutics | 1.70B |
| Stoke Therapeutics | 1.69B |
| Generate Biomedicines | 1.67B |
| Intellia Therapeutics | 1.66B |
| Ultragenyx Pharmaceutical | 1.65B |
| Immunocore Holdings | 1.63B |